A Phase 2b, Randomized, Double-blind, Placebo-Controlled Multicenter Study Evaluating Antiviral Effects, Pharmacokinetics, Safety, and Tolerability of Presatovir in Hematopoietic Cell Transplant Recipients with Respiratory Syncytial Virus Infection of the Lower Respiratory TractFrancisco M. Marty, Sanjeet Dadwal, Polina German et al.|Clinical Infectious Diseases|2019Cited by 76
A Phase 2, Randomized, Double-blind, Placebo-Controlled Trial of Presatovir for the Treatment of Respiratory Syncytial Virus Upper Respiratory Tract Infection in Hematopoietic-Cell Transplant RecipientsRoy F. Chemaly, Michael Boeckh, Hans H. Hirsch et al.|Clinical Infectious Diseases|2019Cited by 75